AE spectrum similar, frequency varies for 2nd-gen antidepressants Clinical study 19 January 2013 Pages: 1 - 1
The US FDA has issued an early communication about its ongoing safety review of tiotropium bromide [Spiriva HandiHaler] Media release 19 January 2013 Pages: 2 - 2
5-α-reductase inhibitor use does not appear to be associated with an increased risk of hip fracture Clinical study 19 January 2013 Pages: 3 - 3